The CCR4/CCR6 chemokine system score was lower in tumor regression grading (TRG) of grade 0/1 compared to patients with TRG2/3, suggesting that the CCR4/CCR6 chemokine system would be a potential biomarker (28). This evidence concerns the gene CCR6 and neoplasm.